Quantcast

Latest Colorectal cancer Stories

2014-08-01 16:23:54

Plasma RNA biomarker panel for colorectal cancer screening JERUSALEM, Aug. 1, 2014 /PRNewswire-iReach/ -- Bio-MarCare Technologies, a leader in the development of plasma RNA biomarkers for colorectal cancer (CRC), is offering for sale its proprietary Colon-MarCarePlex(TM) technology for the pre-cancerous polyps screening in blood. The purchaser will receive all intellectual property (IP) rights, know-how and current business relationships associated with MarCarePlex(TM) technology....

2014-08-01 16:23:45

AUSTIN, Texas, Aug. 1, 2014 /PRNewswire/ -- XBiotech has enrolled the first patient into its European Phase III study using its novel cancer drug Xilonix(TM) for the treatment of colorectal cancer. The double-blinded placebo controlled study is evaluating the use of the monoclonal antibody therapy designed to block chronic inflammation associated with malignant tumor growth. The treatment is reportedly aimed at reversing disease symptoms associated with disease progression and...

2014-07-23 23:24:51

Allen Kamrava, M.D., a Board-certified colorectal surgeon in Los Angeles, has launched a website devoted to the treatment of colon cancer, hemorrhoids, and other colorectal conditions. Beverly Hills, CA (PRWEB) July 22, 2014 Dr. Allen Kamrava, colorectal surgeon in Beverly Hills, is pleased to announce the launch of a new website dedicated to the diagnosis and treatment of various colorectal conditions. The website can be found at DrKamrava.com. “With this new website, I am able to...

2014-07-23 23:18:30

Transparency Market Research published a new report "Circulating Tumor Cells (CTCs) Prognostic Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" to its report store. Browse the full report: http://www.transparencymarketresearch.com/ctcs-prognostic-technologies-market.html Albany, New York (PRWEB) July 22, 2014 According to a new market report published by Transparency Market Research “Circulating Circulating Tumor Cells (CTCs)...

2014-07-18 11:19:12

Cell Press Colorectal cancer has been linked to carbohydrate-rich western diets, but the underlying mechanisms have been unclear. A study published by Cell Press July 17th in the journal Cell shows that gut microbes metabolize carbohydrates in the diet, causing intestinal cells to proliferate and form tumors in mice that are genetically predisposed to colorectal cancer. Treatment with antibiotics or a low-carbohydrate diet significantly reduced tumors in these mice, suggesting that these...

2014-07-15 12:42:23

St. Michael's Hospital Ontario spent nearly $110 million dollars between 2006 and 2010 on bonuses to motivate family doctors to screen more of their patients for cancer but these bonuses were associated with little or no improvement in actual cancer screening rates, according to researchers at St. Michael's Hospital and the Institute for Clinical Evaluative Sciences (ICES). The study, published today in Annals of Family Medicine, tracked screening rates for cervical, breast and...

2014-07-14 12:48:10

Dana-Farber Cancer Institute Study pinpoints a molecular cause of cachexia, and hints at a potential treatment New research raises the prospect of more effective treatments for cachexia, a profound wasting of fat and muscle occurring in about half of all cancer patients, raising their risk of death, according to scientists from Dana-Farber Cancer Institute. Many strategies have been tried to reverse the condition, which may cause such frailty that patients can't endure potentially...

2014-07-01 15:14:56

Universitat Basel The risk of developing cancer increases with age. Factors like smoking and regular aspirin use also affect the risk of cancer – although in the opposite sense. Researchers from the University of Basel were now able to show that aspirin use and smoking both influence aging processes of the female genome that are connected to colorectal cancer. The Journal of the National Cancer Institute has published their results. Already in the 1990s, scientists discovered that...

2014-06-30 13:06:13

European Society for Medical Oncology ESMO 16 World GI Congress on Gastrointestinal Cancer The new combination agent TAS-102 is able to improve overall survival compared to placebo in patients whose metastatic colorectal cancer is refractory to standard therapies, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona. "Around 50% of patients with colorectal cancer develop metastases but eventually many of them do not respond to standard therapies,"...

2014-06-30 12:40:20

European Society for Medical Oncology ESMO 16 World GI Congress on Gastrointestinal Cancer For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona. "The CALGB/SWOG 80405 trial was designed and formulated in 2005, and the rationale was simple: we had new drugs --bevacizumab and cetuximab-- and the study...


Latest Colorectal cancer Reference Libraries

Sigmoidoscopy
2013-03-04 10:30:47

Sigmoidoscopy is a medical procedure in which the physician is able to visualize the inside walls of the large intestine with a scope placed in the rectum. Only the distal part of the colon, or the sigmoid, is examined as opposed to the entire bowel in a colonoscopy. Reasons for procedure The use of this procedure is mainly for early detection of colorectal cancer, vascular abnormalities or polyps. Studies have shown that this procedure has aided in early detection of colorectal cancer...

More Articles (1 articles) »
Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related